ApicHope(SZ:300723) Sou Hu Cai Jing·2025-09-16 17:48Group 1 - The stock price of Yipinhong (300723) closed at 60.35 yuan on September 16, 2025, down 2.99% with a turnover rate of 1.55% and a trading volume of 64,800 shares, amounting to a transaction value of 393 million yuan [1] - On September 16, the net outflow of main funds was 45.6391 million yuan, while the net inflow from speculative funds and retail investors was 21.6322 million yuan and 24.0069 million yuan, respectively [1][3] Group 2 - Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., received a drug registration certificate for Clindamycin Palmitate Granules from the National Medical Products Administration. This drug is classified as a Category 3 chemical drug with a specification of 1.5g and a shelf life of 48 months [1] - The drug is indicated for severe infections caused by sensitive anaerobic bacteria, streptococci, pneumococci, and staphylococci, particularly for patients allergic to penicillin. The product is also a Category B product under the national medical insurance scheme and is considered to have passed the consistency evaluation [1] - The expected sales scale of this drug in urban and county-level public hospitals in China for 2024 is approximately 100.3 million yuan. The approval of this product will enhance the company's product pipeline and strengthen its competitiveness in the anti-infection field [1]